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Introduction
This article consists of a short introduction to
the reviews presented in this series. It focuses on
the contribution of the work of the Child Health
Epidemiology Reference Group (CHERG) to the
Lives Saved Tool (LiST) through the development of
estimates of key inputs to the model. These include
previously estimated country-specific distribution of
the main causes of under-5 deaths and of the propor-
tion of these deaths that can be averted by specific
interventions (affected fraction), along with the newly
estimated efficacy/effectiveness of child survival inter-
ventions that are presented in detail in individual
papers in this volume. This series reflects our efforts
to make all data, materials and methods used in
the estimation of parameters fully available and
transparent.
The CHERG
The CHERG was established by the World Health
Organization (WHO) in 2001 to address the inade-
quacy of existing data and methods and the difficulty
in documenting progress and identifying gaps in child
health epidemiology. The CHERG has established
itself as a unique source for independent technical
work that responds to the main epidemiological ques-
tions in child health. It is composed of international
experts that are external to and independent from the
UN system. The main initial objectives of the group
were: (i) to provide global technical leadership in the
development and improvement of epidemiological
estimates for children under five, particularly regard-
ing cause-specific morbidity and mortality; (ii) to
address general methodological issues; and (iii) to
assess the potential contribution and impact of inter-
ventions to reduce under-5 mortality. The group’s
working method usually starts by convening small
technical working groups to address key questions;
by conducting extensive systematic reviews, analyses
and modelling to develop estimates; and assembling
regular meetings that involve the lead scientists
from the groups. These meetings are convened by
WHO and UNICEF and occur approximately every
six months to define future work and report on pro-
gress and also to provide peer review, thus ensuring
high quality and transparency.
CHERG’s primary mandate was to review and
improve data collection, methods and assumptions
underlying estimates of the cause-specific distribution
of deaths due to the major causes of child mortality
worldwide: causes of death in the first 28 days of life
(neonatal causes); pneumonia; diarrhoea; malaria;
and measles.
1–6 CHERG has also provided estimates
of important childhood morbidities such as pneumo-
nia
7,8 and malaria.
9 In addition, substantial new
information on etiology has become available in
2009.
10–12 More recently, a thorough re-examination
of previous reviews
13,14 on the effectiveness of differ-
ent child survival interventions has been carried out
by CHERG working groups and is presented in detail
in this series.
The Lives Saved Tool (LiST)
The over-arching goal of the LiST is to promote
evidence-based decision making for planning the
appropriate expansion of maternal, neonatal and
child health interventions and to estimate costs and
budget requirements for their implementation in
low-income countries. Its main objectives are to
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i3estimate the number of lives saved when scaling up
key interventions and to provide a user-friendly tool
for child survival planning in developing countries.
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The tool was developed within the Spectrum software
package and the model enclosed in it is expected to
facilitate the assessment of the impact of different sce-
narios when expanding the coverage of different inter-
ventions, cost these scenarios and make judgements on
the cost-effectiveness of different courses of action.
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The LiST draws on various sources of country-
specific information such as demographic and socio-
economic information; total number of child deaths;
their distribution by cause, health and nutrition sta-
tuses, present and future (user-defined) coverage of
key child survival interventions and their estimated
efficacies and/or effectiveness by cause of death; and
the proportion of deaths that can be averted by a
specific intervention (or the affected fraction).
Information on interventions, cause-of-death profiles
and coverage assumptions have been generated from
the work of WHO and UNICEF, often through the
CHERG. Using this set of information, the model
currently enables the estimation of the number of
deaths that would be averted if specific interventions
had their coverage expanded. Figure 1 shows a
diagram with inputs needed to the model and their
schematic flow.
CHERG and LiST
In the last few years, there have been major advances
in gathering key information needed for planning
at the country level. As part of its ongoing work on
reviewing and documenting child health information,
the CHERG and its partners have been collaborating
with the LiST project by providing estimates for
three of the five key parameters used in the tool
model: ‘causes of death, affected fractions and
impact of interventions’.
Causes of death included in the model consist
of: pneumonia, diarrhoea, malaria, measles, AIDS
and neonatal causes of mortality (prematurity, birth
asphyxia, severe infections, tetanus, congenital
anomalies and diarrhoea). Low birth weight and
stunting are treated as contributory factors to
the above-mentioned causes of death. The cohort
approach used in the model allows for specific nutri-
tional factors to contribute deaths in different periods
of life. For example, intrauterine growth restriction
contributes to deaths not only in the neonatal
period, but also, via stunting, in subsequent periods
of a child’s life cycle. In these subsequent periods,
stunting is impacted by infant and child nutrition
interventions. The cause-of-death estimation process
carried out by the CHERG involved the undertaking
of systematic, extensive and comprehensive literature
reviews of published studies and the development of
a methodological approach that is transparent and
consistent across different diseases. Details of the esti-
mation process have been described elsewhere.
2,3
The proportion of deaths that can be averted by spe-
cific interventions such as vaccines has also been esti-
mated. Rotavirus vaccine, for example, can only avert
diarrhoea deaths that are due to Rotavirus; therefore,
its estimated effectiveness can only be applied to this
‘fraction’ of diarrhoea deaths. Similarly, Hib and
Pneumococcal vaccines can only avert those pneumo-
nia deaths that are due to Haemophilus influenzae type
b (Hib) and Streptococcus pneumoniae, respectively. The
proportion of diarrhoea deaths due to Rotavirus and
of pneumonia deaths due to Hib and to pneumo-
coccus have been estimated by CHERG and its
partners.
10–12
The main focus of this series, however, is on the
CHERG’s process for estimating the impact of key child-
hood interventions on the survival of children younger
than five years of age. The main goal of the reviews
presented in this series is to estimate the magnitude
of the effect of the intervention on a specific cause of
death. In order to achieve this objective, we first estab-
lished criteria for the inclusion of interventions in the
tool, based on two axes: ‘the likely impact of the inter-
vention and the evidence of its effect’. The first criteria
determined the inclusion of (i) interventions that are
likely to have an impact on a cause of death that is
relevant in at least some settings (e.g. areas with high
malaria or HIV burden); and (ii) interventions that are
not likely to have an impact on mortality because of its
current high coverage, but that would probably result
in an increase of mortality where coverage levels are not
sustained (e.g. measles and DPT vaccines). The criteria
based on evidence of effectiveness established that,
to be included in the tool, the intervention should
have (i) at least some documented evidence of a
direct effect on cause-specific mortality, on all cause
mortality or on severe morbidity or (ii) a higher level
of evidence of a direct effect on mild/moderate morbid-
ity or (iii) clear and indubitable clinical benefit (e.g.
C-section for obstructed labour or foetal distress and
antibiotics for infection).
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Figure 1 Inputs to the LiST tool and schematic flow
Source: Stover J. Presentation given at the CHERG meeting
in June 2008
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of the LiST, we started the process to estimate the
magnitude of their effect on specific causes of
death. The first step consisted of a Cochrane-type sys-
tematic literature review using at least PubMed,
Cochrane reviews and the WHO Regional Databases.
Whenever Cochrane reviews were used, these were
revisited and reappraised, meaning that studies were
reassessed or reviewed yet again. For many interven-
tions, the evidence for an effect on cause-specific
mortality was fairly weak, requiring therefore more
in-depth literature searches on different study designs
and/or on outcomes other than mortality. Because the
specific aim of the reviews was to estimate the effect
of an intervention on cause-specific mortality, the
CHERG developed a series of rules for combining lim-
ited cause-specific mortality data with all-cause mor-
tality, serious morbidity and moderate morbidity data
in order to estimate the final effect (and uncertainty
bounds) of each intervention in reducing cause-
specific mortality. These rules are presented in detail
by Cousens et al.
16 The final combined estimates will
be those used as input to the LiST of the effect of
increased coverage of a specific intervention on
cause-specific mortality and thus the number of
lives saved by scaling up such an intervention.
The CHERG developed a standardized abstraction
table for use across all technical groups and all inter-
ventions in which information on the main character-
istics of the studies retained for analysis were
abstracted and presented. Such information comprise:
(i) study identifiers and context such as author, year
of publication, journal reference, country where and
year when the study was carried out, etc; (ii) charac-
teristics of study design and assessment of its limita-
tions; (iii) characteristics of the intervention in the
specific study (definition, delivery channel, target
population, etc); (iv) definition of outcome (under-5
mortality, neonatal mortality, morbidity, etc) and
impact of intervention on study-specific outcome;
and (v) summary of characteristics, including overall
study limitations and evaluation of the directness of
the effect on studied outcome in relation to the out-
come of interest.
Meta-analyses were then performed for each out-
come and by each type of study design as appropriate.
Whenever the evidence for an effect on cause-specific
mortality was identified to be weak, a series of
assumptions had to be made,
17 which resulted in
more complex and stringent methods than standard
randomized control trials pooled- or meta-analyses
and in more conservative effect estimates.
The last step of the review process was the applica-
tion of the Grading of Recommendations Assessment,
Development and Evaluation (GRADE).
17 The GRADE
approach assesses the risk of bias in individual studies
as well as the quality of the assembled evidence on
the effect of each intervention on the outcome of
interest. The latter is classified as high, moderate,
low or very low. For example, randomized trials
are initially categorized as high quality but can be
downgraded; similarly, observational studies can be
upgraded. Factors that decrease the quality of evi-
dence include limitations in design, indirectness of
evidence, unexplained heterogeneity or inconsistency
of results, imprecision of results, or high probability of
publication bias. Factors that can increase the quality
level of a body of evidence include large magnitude of
effect, if all plausible confounding would reduce a
demonstrated effect and a dose-response gradient.
Final assessment of the overall quality of evidence
and a summary of its GRADE appraisal are presented
in each individual paper in a pre-defined table format.
CHERG and LiST: uniting efforts
for the achievement of MDG4
It has been estimated that universal coverage of avail-
able interventions could prevent about two-thirds
of childhood deaths.
13 Some recent analysis provided
further evidence that increases in coverage of key inter-
ventions are associated with reductions in under-5
mortality.
18 Consequently, specific efforts for improv-
ing coverage of these key interventions is a possible
means for health programmes to contribute to the
achievement of the Millennium Development Goal
4 (MDG4).
The CHERG and LiST projects share the common
objective of providing policy makers with the best
available evidence that will enable informed decisions
to be made regarding maternal, neonatal and child
survival. Our ultimate goal is that the information
provided through this new tool will be used for plan-
ning purposes in countries and districts; more specif-
ically, helping to define what interventions are
most needed and to guide the introduction and scal-
ing up of strategic interventions. An integrated and
user-friendly tool for use by countries has the poten-
tial to facilitate:
(i) evidence-based policy guidance
(ii) results-based strategies and plans for maternal,
newborn and child survival programmes and
(iii) inputs for sector budgets and medium term
expenditure frameworks (MTEFs)
In conclusion, this common effort should provide
the necessary support, encouragement and opportu-
nity to help policy makers and programme managers
in countries, and donors and international agencies to
set clear coverage targets, implement effective strate-
gies and monitor progress of their achievement.
Future plans for joint CHERG-LiST
work
Work is underway to also include in LiST costing
modules and estimated impact of interventions on
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costing tools such as the World Bank and UNICEF’s
Marginal Budgeting for Bottleneck (MBB) tool and
the WHO supported costing tool for child survival
are being developed and will allow the estimation of
costs for scenarios of increased coverage generated by
LiST. The approach to estimating the impact of inter-
ventions on maternal mortality and stillbirths is very
similar to that used for child mortality. For each
country, causes and levels of maternal deaths and
stillbirths have been defined. Evidence is also being
collected on the effects of interventions that have an
impact on these two outcomes yielding estimates of
the reduction in maternal deaths and stillbirths with
the scaling up of these interventions. This work is
currently being carried out within the CHERG, but
has also strong links with groups that have a greater
focus on stillbirths such as GAPPS. The most recent
version of LiST along with documentation and
training materials can be viewed and downloaded at
HYPERLINK ‘‘http://www.jhsph.edu/dept/IH/IIP/list’’
www.jhsph.edu/dept/IH/IIP/list. More information
about CHERG can be found at HYPERLINK ‘‘http://
www.cherg.org’’ www.cherg.org.
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